Outlook Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
OTLK
CUSIP
69012T305
Type
Equity
Class
COM
Num filings
1
Total reported value, excl. options
$59.5 k
Manager Report Date Value ($000) Shares Option Type